1. Project Description
Project Name: MedikhanaX
Token Name: MKX
2. Project Introduction
Medikhana is headquartered in Singapore and provides quality assurance focused on agricultural industries by using blockchain, offers clients with cultivation technology using the Japanese Agricultural IoT system, as well as supports clients to obtain cannabis related licenses for those looking for cannabis business establishment in Southeast Asia. In the meantime, MedikhanaX supports distributing and retailing cannabis related products, grown and/or manufactured by clients.
Medikhana’s Competitive Advantages:
A. Medikhana has the first-mover advantage in its Japanese quality × CBD Business × Blockchain model.
B. Medikhana supported products are demonstrably of the best quality. The high-end Japanese facilities, equipment, and technology exceed international standards, and blockchain allows consumers to see for themselves that their products are of the highest quality and safe.
C. By using blockchain to establish an integrated business, from cannabis cultivation to manufacturing of CBD products, distribution, and sales, Medikhana improves the thoroughness and accuracy of the management and control of CBD products. Use of blockchain creates transparency in a market that is rife with unethical operators.
D. Use of blockchain, IoT, and other state-of-the-art technologies to drive AgriTech creates secure, transparent, and highly efficient CBD production and facilitates both partnering with others and quickly growing the company’s value.
E. With the utilization of the combination of blockchain, IoT and AgriTech and the Reiwa factory as an anchor, the building blocks for the development of an cannabis industrial park that will evolve into a smart city are being laid.
F. In order to promote its CBD business, Medikhana has issued MKX (MedikhanaX) tokens. MKX will be available to trade on Medikhana’s own decentralized finance platform (Defi), which is plan to launch in Q1 of 2022.
G. Medikhana’s base in Singapore, an international market hub, is an ideal location for its business and regulatory environment.
H. Thailand production location is ideal from perspectives such as climate, business and regulatory environment. Siam Reiwa (2020) Co., Ltd., a Medikhana partner company, has built a Japanese quality factory, completed a rigorous certification process and begun cultivation, while competitors are still struggling.
I. Medikhana grows high-quality cannabis and produces groundbreaking CBD products using the most advanced AgriTech through technical exchanges with companies in Israel, the global hub of AgriTech farms and leader in medical cannabis. In addition, total quality control (TQC) is performed by adhering to SOPs (Standard Operating Procedures)
J) Medikhana has assembled an accomplished team of managers and advisors with experience and proven track records in their respective fields.
3. Token overview
Total Supply: 5,000,000,000 MKX